Vaccine Slows Return of Pancreatic Cancer in Early Trial
THURSDAY, May 11, 2023 – A gene-targeted personalized vaccine may delay the return of pancreatic cancer according to a small, but promising, trial.
The mRNA vaccine, which was tailored to the genetic makeup of each patient ' s tumor, worked in half...
Source: Drugs.com - Daily MedNews - Category: General Medicine Source Type: news
More News: Cancer | Cancer & Oncology | Cancer Vaccines | General Medicine | Genetics | Pancreas | Pancreatic Cancer | Vaccines